Evidence map›Paper›PMID 33651741›Full record

ArticleMenopause (New York, N.Y.)2021

Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN heart study.

Saad Samargandy, Karen A Matthews, Maria M Brooks, Emma Barinas-Mitchell, Jared W Magnani, Imke Janssen, Rasa Kazlauskaite, Samar R El Khoudary

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Menopause (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06975111 (Focusing on the Menopausal Transition to Improve Mid-Life Women's Health), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06975111 phase2 / phase3recruitingstarted 2026, after this paper: background citation

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Ran2026Enrolled200Registered outcomes10Posted comparisons0ConditionsCardiovascular, Menopause, Menopause Hot Flashes, Menopause Related ConditionsArmsAnti-hypertensives, Fezolinetant, Hormonal therapy, Life Style Intervention, Lipid Lowering Medication
Open the trial in the graph
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Menopause is a physiological progression event for women with multiple sclerosis: No.Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy.International journal of molecular sciences · 2025
    Review
  18. Review
  19. Understanding the menopause journey.Climacteric : the journal of the International Menopause Society · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Saad SamargandyGraduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Karen A MatthewsDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA.
Maria M BrooksGraduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Emma Barinas-MitchellGraduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Jared W MagnaniDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA.
Imke JanssenDepartment of Preventive Medicine, Rush University, Chicago, IL.
Rasa KazlauskaiteDepartment of Medicine, Rush University, Chicago, IL.
Samar R El KhoudaryGraduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · USAmerican Heart Association · USRush University · US

Funding

The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old AgeU19AG063720 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHERRI-ANN M BURNETT-BOWIE · 2020 to 2026
$61.3M
WOMENS HEALTH ACROSS THE NATION--COORDINATING CENTERU01AG012553 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BROOKS, MARIA MORI · 1994 to 2019
$37.7M
WOMENS HEALTH ACROSS THE NATION--ENDOCRINE LABU01AG012495 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCCONNELL, DANIEL S · 1994 to 2018
$18.8M
WOMENS HEALTH ACROSS THE NATION--PITTSBURGHU01AG012546 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MATTHEWS, KAREN · 1994 to 2019
$16.2M
WOMENS HEALTH ACROSS THE NATION--UCDAVISU01AG012554 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI GOLD, ELLEN B. · 1994 to 2019
$14.5M
WOMENS HEALTH ACROSS THE NATION--UCLAU01AG012539 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GREENDALE, GAIL A · 1994 to 2018
$13.7M
THE STUDY OF WOMEN'S HEALTH ACROSS THE NATION-MICHIGANU01NR004061 · NINR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HARLOW, SIOBAN D · 1994 to 2018
$12.9M
WOMENS HEALTH ACROSS THE NATION--CHICAGOU01AG012505 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI KRAVITZ, HOWARD M · 1994 to 2019
$11.9M
WOMENS HEALTH ACROSS THE NATION--MASSACHUSETTS GENERAL HU01AG012531 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI FINKELSTEIN, JOEL S · 1994 to 2019
$10.7M
Women's Health Across the Nation-New Jersey SiteU01AG012535 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DERBY, CAROL A. · 1994 to 2019
$9.2M
PREVALENCE &PROGRESSION OF SUBCLINICAL ATHEROSCLEROSISR01HL065591 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TYRRELL, KIM SUTTON · 2000 to 2003
$2.6M
PREVALENCE &PROGRESSION OF SUBCLINICAL ATHEROSCLEROSISR01HL065581 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI POWELL, LYNDA H · 2000 to 2003
$1.9M
NHLBI NIH HHS R01 HL065581NHLBI NIH HHS R01 HL065591NIA NIH HHS U01 AG012495NIA NIH HHS U01 AG012505NIA NIH HHS U01 AG012531NIA NIH HHS U01 AG012535NIA NIH HHS U01 AG012539NIA NIH HHS U01 AG012546NIA NIH HHS U01 AG012553NIA NIH HHS U01 AG012554NIA NIH HHS U19 AG063720NINR NIH HHS U01 NR004061
6 · The paper itself

Abstract

objectivesTo characterize abdominal visceral adipose tissue (VAT) trajectory relative to the final menstrual period (FMP), and to test whether menopause-related VAT accumulation is associated with greater average, common carotid artery intima-media thickness (cIMT) and/or internal carotid artery intima-media thickness (ICA-IMT).

methodsParticipants were 362 women (at baseline: age was (mean ± SD) 51.1 ± 2.8 y; 61% White, 39% Black) with no cardiovascular disease from the Study of Women's Health Across the Nation Heart study. Women had up to two measurements of VAT and cIMT over time. Splines revealed a nonlinear trajectory of VAT with two inflection points demarcating three time segments: segment 1: >2 years before FMP; segment 2: 2 years before FMP to FMP; and segment 3: after FMP. Piecewise-linear random-effects models estimated changes in VAT. Random-effects models tested associations of menopause-related VAT with each cIMT measure separately. Estimates were adjusted for age at FMP, body mass index, and sociodemographic, lifestyle, and cardiovascular disease risk factors.

resultsVAT increased significantly by 8.2% (95% CI: 4.1%-12.5%) and 5.8% (3.7%-7.9%) per year in segments 2 and 3, respectively, with no significant change in VAT within segment 1. VAT predicted greater ICA-IMT in segment 2, such that a 20% greater VAT was associated with a 2.0% (0.8%-3.1%) greater ICA-IMT. VAT was not an independent predictor of ICA-IMT in the other segments or of the other cIMT measures after adjusting for covariates.

conclusionsWomen experience an accelerated increase in VAT starting 2 years before menopause. This menopause-related increase in VAT is associated with greater risk of subclinical atherosclerosis in the internal carotid artery.

Indexed as

Carotid Artery DiseasesCarotid Intima-Media ThicknessAbdominal FatCarotid ArteriesFemaleHumansIntra-Abdominal FatMenopauseRisk Factors

Identifiers

PMID33651741
PMCPMC8141004
OpenAlexW3133952143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.